Factors Contributing to Exacerbating Vulnerabilities in Global Clinical Trials
Background: Although policies and guidelines make use of the concept of vulnerability, few define it. The European Union's directive for clinical trials does not include explanations for or the reasoning behind the designation of certain groups as vulnerable. Emerging economies from lower middl...
Saved in:
Main Authors: | Ricardo E. da Silva (Author), Angélica A. Amato (Author), Dirce B. Guilhem (Author), Marta R. de Carvalho (Author), Elisangela da C. Lima (Author), Maria Rita C. G. Novaes (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2018-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
International Clinical Trials in Latin American and Caribbean Countries: Research and Development to Meet Local Health Needs
by: Ricardo E. da Silva, et al.
Published: (2018) -
The High "Cost" of Experimental Drugs Obtained Through Health Litigation in Brazil
by: Ricardo Eccard da Silva, et al.
Published: (2020) -
National governance and excess mortality due to COVID-19 in 213 countries: a retrospective analysis and perspectives on future pandemics
by: Ricardo Eccard da Silva, et al.
Published: (2023) -
The impact of social cohesion and risk communication on excess mortality due to COVID-19 in 213 countries: a retrospective analysis
by: Ricardo Eccard da Silva, et al.
Published: (2024) -
Scientific integrity
by: Maria Rita Carvalho Garbi Novaes, et al.
Published: (2017)